Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart and Lung Institute, Laval University, Québec, Canada.
J Am Coll Cardiol. 2012 Oct 2;60(14):1259-67. doi: 10.1016/j.jacc.2011.12.054. Epub 2012 May 30.
The aim of this case match study was to compare the outcome of patients with paradoxical low-flow (left ventricular ejection fraction [LVEF] ≥50% but stroke volume index <35 ml/m(2)), low-gradient (mean gradient [MG] <40 mm Hg), a priori severe (aortic valve area [AVA] ≤1.0 cm(2)) aortic stenosis (AS) (PLG-SAS group) with that of patients with a severe AS (AVA ≤1.0 cm(2)) and consistent high-gradient (MG ≥40 mm Hg) (HG-SAS group) and with that of patients with a moderate AS (AVA >1.0 cm(2) and MG <40 mm Hg) (MAS group).
In patients with preserved LVEF, a discordance between the AVA (in the severe range) and the gradient (in the moderate range) raises uncertainty with regard to the actual severity of the stenosis and thus the therapeutic management of the patient.
In a prospective cohort of AS patients with LVEF ≥50%, we identified 187 patients in the PLG-SAS group. These patients were retrospectively matched: 1) according to the gradient, with 187 patients with MAS; and 2) according to the AVA, with 187 patients with HG-SAS.
Patients with PLG-SAS had reduced overall survival (1-year: 89 ± 2%; 5-year: 64 ± 4%) compared with patients with HG-SAS (1-year: 96 ± 1%; 5-year: 82 ± 3%) or MAS (1-year: 96 ± 1%; 5-year: 81 ± 3%). After adjustment for other risk factors, patients with PLG-SAS had a 1.71-fold increase in overall mortality and a 2.09-fold increase in cardiovascular mortality compared with the 2 other groups. Aortic valve replacement was significantly associated with improved survival in the HG-SAS group (hazard ratio: 0.18; p = 0.001) and in the PLG-SAS group (hazard ratio: 0.50; p = 0.04) but not in the MAS group.
Prognosis of patients with paradoxical low-flow, low-gradient severe AS was definitely worse than those with high-gradient severe AS or those with moderate AS. The finding of a low gradient cannot exclude the presence of a severe stenosis in a patient with a small AVA and preserved LVEF and should mandatorily prompt further investigation.
本病例对照研究旨在比较左心室射血分数(LVEF)≥50%但每搏量指数(stroke volume index)<35ml/m²的矛盾性低流量( paradoxical low-flow)、低梯度(mean gradient<40mmHg)、术前严重(aortic valve area≤1.0cm²)主动脉瓣狭窄(aortic stenosis,AS)(PLG-SAS 组)患者的预后与高梯度严重 AS(mean gradient≥40mmHg)(HG-SAS 组)和中梯度严重 AS(mean gradient<40mmHg)(MAS 组)患者的预后,并与中梯度严重 AS 患者的预后进行比较。
在 LVEF 保留的患者中,AVA(处于严重范围)与梯度(处于中度范围)之间的不匹配引起了对狭窄实际严重程度的不确定性,从而导致患者的治疗管理不确定。
在 LVEF≥50%的 AS 患者前瞻性队列中,我们确定了 187 例 PLG-SAS 组患者。这些患者进行了回顾性匹配:1)根据梯度,与 187 例 MAS 患者匹配;2)根据 AVA,与 187 例 HG-SAS 患者匹配。
PLG-SAS 组患者的总生存率降低(1 年:89±2%;5 年:64±4%),与 HG-SAS 组(1 年:96±1%;5 年:82±3%)或 MAS 组(1 年:96±1%;5 年:81±3%)相比。调整其他危险因素后,PLG-SAS 组患者的总死亡率增加 1.71 倍,心血管死亡率增加 2.09 倍,与其他两组相比。在 HG-SAS 组(危险比:0.18;p=0.001)和 PLG-SAS 组(危险比:0.50;p=0.04)中,主动脉瓣置换与生存率的改善显著相关,但在 MAS 组中没有。
矛盾性低流量、低梯度严重 AS 患者的预后明显差于高梯度严重 AS 患者或中梯度严重 AS 患者。低梯度的发现不能排除小 AVA 和保留的 LVEF 患者存在严重狭窄,应强制进行进一步检查。